生物补片与合成补片修补造口旁疝的长期结局:多中心随机试验事后分析
该研究为多中心随机临床试验的事后分析,纳入108例同期行开放腹膜前腹壁疝修补并造口旁疝修补的患者,比较生物补片与合成补片的5年结局。88例(81.5%)完成5年随访(中位5.9年),造口旁疝复发率为33.6%(生物补片37.5% vs 合成补片29.4%)。校正混杂因素后,合成补片与复发风险降低45%相关(HR=0.65,95%CI 0.44-0.96,P=0.028),两组补片相关并发症无差异。
要点
- 合成补片组5年造口旁疝复发风险显著低于生物补片组(HR=0.65)。
- 两组补片相关并发症在2年后无新发,再手术率无显著差异。
- 腹膜前补片构型(Sugarbaker vs 钥匙孔)对复发无显著影响。
核心结论
- 与生物补片相比,合成补片与5年造口旁疝复发率显著降低相关,且补片相关并发症无差异。
研究设计与样本
- 多中心随机临床试验(NCT#02451176)的事后分析,纳入108例同期行开放腹膜前腹壁疝修补和造口旁疝修补的患者。
主要发现
- 88例(81.5%)完成5年随访,中位随访5.9年。
- 造口旁疝总复发率为33.6%,生物补片组37.5%,合成补片组29.4%。
- 15例(14%)接受再手术,其中生物补片组9例,合成补片组6例。
- 校正混杂因素后,合成补片与复发风险降低45%相关(HR=0.65,95%CI 0.44-0.96,P=0.028)。
- 2年后无新发补片相关并发症;腹膜前补片构型亚组分析显示复发率无差异(25.9% vs 36.3%,P=0.358),无复发生存期亦无差异(log rank P=0.33)。
临床怎么用
- 在开放腹膜前腹壁疝修补同期行造口旁疝修补时,可优先考虑合成补片以降低远期复发风险。
局限性
- 为事后分析,样本量有限(108例),结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Here we aimed to examine the outcomes of parastomal hernia repair after 5 years in patients undergoing concomitant open retromuscular ventral hernia repair randomized to biologic or synthetic mesh as part of a clinical trial (NCT#02451176). SUMMARY OF BACKGROUND DATA: Previously, we reported that parastomal hernia recurrence rates at 2 years were similar between treatment arms with no difference in mesh-related complications. Long-term data on parastomal hernia repair outcomes is otherwise sparse. METHODS: We conducted a post-hoc analysis of the aforementioned multicenter clinical trial (December 2012-April 2019) specifically looking at patients undergoing concomitant parastomal hernia repair during open retromuscular ventral hernia repair. Exploratory outcomes included rates of parastomal hernia recurrence, mesh-related complications, and reoperation. Cox proportional hazards models were constructed to estimate hazard ratios for parastomal hernia recurrence associated with mesh type, adjusting for potential confounders including age, sex, race, BMI, smoking status, mesh defect ratio, and mesh size. Subgroup analysis of mesh configuration (retromuscular Sugarbaker vs keyhole) was also performed. RESULTS: Of 108 patients, 88 (81.5%) achieved five-year follow-up (median 5.9 y). The parastomal hernia recurrence rate was 33.6% (37.5% biologic versus 29.4% synthetic mesh), of which 15 (14%) underwent reoperation (9 biologic, 6 synthetic). Following adjustment for confounders, synthetic mesh demonstrated a 45% reduction in recurrence risk (HR=0.65, 95% CI: 0.44-0.96, P=0.028). No new mesh-related complications occurred beyond two years. Subgroup analysis of retromuscular mesh configuration showed no difference in parastomal recurrence rate (25.9% vs. 36.3%; P=0.358) or recurrence-free survival (log rank P=0.33). CONCLUSIONS: Synthetic mesh was associated with significantly lower long-term parastomal hernia recurrence rates compared to biologic mesh at 5 years with no difference in mesh-related complications.
引用
- Remulla DB, Bansal B, Bennett WC, et al. Long-term Outcomes of Biologic versus Synthetic Mesh for Parastomal Hernia Repair: Post-Hoc Analysis of a Multicenter Randomized Clinical Trial. Ann Surg. 2026. PMID: 41731647. doi:10.1097/SLA.0000000000007027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。